Company: IPSC
Filing Date: 2025-06-16
Form Type: 8-K
Source: 0001104659-25-059950
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-06-16
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission                                 

On June 12,2025, Century Therapeutics, Inc. (the “ Company”) held its 2025 Annual Meeting of Stockholders (the “ Annual Meeting”).
As of April 16, 2025, the record date for the Annual Meeting, there were 86,158,758 outstanding shares of the Company’s common
stock. The Annual Meeting was conducted virtually, and the following is a brief description of the final voting results for each of the
proposals submitted to a vote of the stockholders at the Annual Meeting, which are described in detail in the Company’s Definitive
Proxy Statement on Schedule 14A filed with the Securities Exchange Commission on April 22, 2025.